Hiroki Takahashi

Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

Athol U. Wells, Kevin R. Flaherty, Kevin K. Brown et al. · The Lancet Respiratory Medicine · 2020 · 522 citations · Full text

Inbuild Trial, Parallel-group Trial, Advanced Lung Disease +5

Proposal for diagnostic criteria for IgG4-related kidney disease

Mitsuhiro Kawano, Takako Saeki, Hitoshi Nakashima et al. · Clinical and Experimental Nephrology · 2011 · 426 citations · Full text

Glomerular Disease, Glomerulonephritis, Urology +11

Direct Binding of Toll-Like Receptor 2 to Zymosan, and Zymosan-Induced NF-κB Activation and TNF-α Secretion Are Down-Regulated by Lung Collectin Surfactant Protein A

Morihito Sato, Hitomi Sano, Daisuke Iwaki et al. · The Journal of Immunology · 2003 · 350 citations · Full text

Serum Surfactant Proteins A and D as Prognostic Factors in Idiopathic Pulmonary Fibrosis and Their Relationship to Disease Extent

Hiroki Takahashi, Takuya Fujishima, Hiroyuki Koba et al. · American Journal of Respiratory and Critical Care Medicine · 2000 · 291 citations

Inflammation, Asthma, Prognostic Factors +15

The prognostic importance of objective nutritional indexes in patients with chronic heart failure

Taro Narumi, Takanori Arimoto, Akira Funayama et al. · Journal of Cardiology · 2013 · 276 citations · Full text

Nutrition, Heart Failure, Body Composition +11